Improved immediate graft function with nifedipine in cyclosporine-treated renal allograft recipients—a randomized prospective study

Transplantation

Volumn 54, Issue 4, 1992, Pages 742-743

  Harper, Steven J ^a   Moorhouse, Jennifer ^a   Veitch, Peter S ^a   Bell, Peter R F ^a   Horsburgh, Terry ^a   Walls, John ^a   Donnelly, Peter K ^a   Feehally, John ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; DILTIAZEM; NIFEDIPINE; VERAPAMIL;

ACIDOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL DEATH; CRYOPROTECTION; DRUG EFFECT; ENZYME ACTIVITY; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT; KIDNEY ISCHEMIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REPERFUSION;

CADAVER; CYCLOSPORINE; GRAFT SURVIVAL; HUMAN; KIDNEY TRANSPLANTATION; NIFEDIPINE; PROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0026758358     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199210000-00037     Document Type: Note

References (15)

1. Taylor RJ, Lanranau MD, Makowka L, et al. Cyclosporine immunosuppression and delayed graft function in 455 cadaveric renal transplants. Transplant Proc 1987; 19: 2100.
2. Lennard TWJ, Parrott NR, Wilson RG, et al. Renal transplantation: the non-starters. Br J Surg 1988; 75: 570.
3. Parrott NR, Forsythe JLR, Matthews JNS, et al. Late perfusion—a simple remedy for renal allograft primary nonfunction. Transplantation 1990; 49: 913.
4. Burnier M, Burke T, Stanley P, Schrier R. Effect of extracellular acidosis on enhanced Ca influx on anoxic renal proximal tubules [Abstract]. Kidney Int 1986; 29: 299.
5. Cheung JY, Bonventre JV, Malis CD, Leaf A. Calcium and ischaemic injury. N Engl J Med 1986; 314: 1670.
6. Schrier RW, Arnold PE, Van Patten VJ, Burke TJ. Cellular calcium in ischaemic acute renal failure. Kidney Int 1987; 32: 313.
7. Dawidson I, Rooth P, Alway C, et al. Verapamil prevents post transplant delayed function and cyclosporin A nephrotoxicity. Transplant Proc 1990; 22: 1379.
8. Wagner K, Albrecht S, Neumayer HH. Influence of calcium antagonist diltiazem on delayed graft function in cadaveric kidney transplantation: results of a six month follow up. Transplant Proc 1987; 19:1353.
9. Dy GR, Raja RM, Mendez MM. The clinical and biochemical effect of calcium channel blockers in organ transplant recipients on cyclosporine. Transplant Proc 1991; 23: 1258.
10. Ferguson CJ, Hillis AN, Williams JD, Griffin PJA, Salaman JR. Calcium channel blockers and other factors influencing delayed function in renal allografts. Nephrol Dial Transplant 1990; 5: 816.
11. McNally PG, Mistry N, Idle JR, Walls J, Feehally J. Calcium channel blockers and cyclosporin metabolism. Transplantation 1989; 48: 1071.
12. Feehally J, Walls J, Mistry N, et al. Does nifedipine ameliorate cyclosporin A nephrotoxicity? Br Med J 1987; 295: 310.
13. Wedner HJ, Parker CW. Lymphocyte activation. Prog Allergy 1976; 20: 95.
14. ++ blockers. Transplantation 1985; 40: 211.
15. Ratcliffe PJ, Richardson AJ, Kirby JE, Moyses C, Shelton JR, Morris PJ. Effect of intravenous infusion of atriopeptide 3 on immediate renal allograft function. Kidney Int 1991; 39: 164.